Amneal Pharmaceuticals, Inc. (AMRX) is in Healthcare, Drug Manufacturers - Specialty & Generic, based in United States, listed on NasdaqGS. Market cap 6.84B USD. 52-week range 9.56 to 21.18 USD. Trailing P/E 40.1. Data as of 2026-10-09.
Amneal Pharmaceuticals, Inc., a global biopharmaceutical company, develops, manufactures, markets, and distributes generics, injectables, biosimilars, and specialty branded pharmaceutical products in the United States, India, Ireland, and internationally. The company operates through three segments: Affordable Medicines, Specialty, and AvKARE. The Affordable Medicines segment offers dosage forms and delivery systems, which include immediate and extended-release oral solids, powders, liquids, ...